4 / 37
INTRODUCCIÓN
Adapted from Halabi S,
J Clin Oncol
2009;27: 2766-2771.
Median Follow-Up of > 4 Years
p = 0.0002
p < 0.0001
p = 0.005
p < 0.0001
p < 0.0001
p = 0.0033
Primary Endpoints: rPFS and OS
Secondary Endpoints
PSA
Progression
Death
ECOG PS Decline
Chemotherapy
Baseline
Tumor/Bone
Progression
Pain
Ryan C et al. ESMO 2014; Abstract 7530 (oral presentation)